A detailed history of Verition Fund Management LLC transactions in Charles River Laboratories International, Inc. stock. As of the latest transaction made, Verition Fund Management LLC holds 1,141 shares of CRL stock, worth $212,819. This represents 0.0% of its overall portfolio holdings.

Number of Shares
1,141
Holding current value
$212,819
% of portfolio
0.0%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$206.39 - $268.73 $235,490 - $306,620
1,141 New
1,141 $235,000
Q4 2022

Feb 14, 2023

SELL
$197.11 - $250.07 $62,680 - $79,522
-318 Reduced 16.33%
1,629 $354,000
Q3 2022

Nov 14, 2022

SELL
$182.44 - $250.54 $92,132 - $126,522
-505 Reduced 20.6%
1,947 $383,000
Q2 2022

Aug 15, 2022

BUY
$204.13 - $302.4 $500,526 - $741,484
2,452 New
2,452 $525,000
Q4 2020

Feb 16, 2021

SELL
$222.0 - $252.62 $426,018 - $484,777
-1,919 Closed
0 $0
Q3 2020

Nov 16, 2020

SELL
$175.56 - $226.45 $609,017 - $785,555
-3,469 Reduced 64.38%
1,919 $435,000
Q2 2020

Aug 14, 2020

BUY
$118.84 - $189.72 $640,309 - $1.02 Million
5,388 New
5,388 $939,000
Q4 2019

Feb 14, 2020

SELL
$126.05 - $152.76 $194,117 - $235,250
-1,540 Closed
0 $0
Q3 2019

Nov 14, 2019

BUY
$125.07 - $143.67 $192,607 - $221,251
1,540 New
1,540 $204,000
Q2 2019

Aug 14, 2019

SELL
$123.4 - $148.55 $464,230 - $558,845
-3,762 Closed
0 $0
Q1 2019

May 15, 2019

SELL
$104.82 - $146.73 $302,615 - $423,609
-2,887 Reduced 43.42%
3,762 $546,000
Q4 2018

Feb 14, 2019

BUY
$105.09 - $137.23 $159,526 - $208,315
1,518 Added 29.58%
6,649 $753,000
Q3 2018

Nov 15, 2018

BUY
$112.11 - $134.54 $575,236 - $690,324
5,131 New
5,131 $690,000
Q2 2018

Aug 15, 2018

SELL
$102.37 - $117.25 $235,246 - $269,440
-2,298 Closed
0 $0
Q1 2018

May 16, 2018

BUY
$98.19 - $115.2 $225,640 - $264,729
2,298 New
2,298 $245,000

Others Institutions Holding CRL

About CHARLES RIVER LABORATORIES INTERNATIONAL, INC.


  • Ticker CRL
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 50,863,300
  • Market Cap $9.49B
  • Description
  • Charles River Laboratories International, Inc., a non-clinical contract research organization, provides drug discovery, non-clinical development, and safety testing services in the United States, Europe, Canada, the Asia Pacific, and internationally. It operates through three segments: Research Models and Services (RMS), Discovery and Safety Ass...
More about CRL
Track This Portfolio

Track Verition Fund Management LLC Portfolio

Follow Verition Fund Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verition Fund Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verition Fund Management LLC with notifications on news.